Royalty Pharma (RPRX) Return on Assets (2020 - 2026)

Royalty Pharma (RPRX) has 7 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Assets rose to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2023 to a low of 0.0% in Q4 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2026 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Tracing RPRX's Return on Assets over 5 years: stood at 0.0% in 2022, then jumped by 691 bps to 0.0% in 2023, then slumped by 30 bps to 0.0% in 2024, then slipped by 7 bps to 0.0% in 2025, then advanced by 1 bps to 0.0% in 2026.
• Business Quant data shows RPRX's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.